You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Spray-based visual indicator of opioids for the rapid and effective decontamination of large areas

    SBC: Triton Systems, Inc.            Topic: CBD20AT001

    Triton Systems, Inc. will collaborate with The University of Massachusetts Lowell to develop a spray-based technology for the rapid, visual identification of opioids, turning contaminated areas from nondescript white powders to a brightly colored spots for easy recognition with the naked eye. The technology leverages molecular recognition units that bind strongly and specifically to a variety of o ...

    STTR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense
  2. Eye-readable Solution-based Dye Displacement Probe for Large-area Detection of Opioids

    SBC: Intelligent Optical Systems, Inc.            Topic: CBD20AT001

    Intelligent Optical Systems, Inc., in collaboration with Bowling Green State University, proposes to develop a field-rugged, eye-readable indicating spray solution that can immediately detect synthetic opioids over a large area of contamination (i.e., military vehicles, individual protective equipment, clandestine labs, etc.). The proposed chemosensor in a spray solution format will detect multipl ...

    STTR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense
  3. Opioid Indicator Spray for Complex Surfaces

    SBC: Clear Scientific, LLC            Topic: CBD20AT001

    Opioids, especially synthetic opioids, are a constant threat to the safety of civilian first responders; there are now serious concerns about their use in modern chemical warfare. Fentanyl and its many analogues (carfentanil, remifentanil, lofentanil, mefentanil, sufentanil, etc.) are extremely hazardous—if ingested or inhaled, many synthetic opioids cause lethal intoxication with only a few gra ...

    STTR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense
  4. Enabling Technology- Reducing Greenhouse Gas Emissions and Energy Demands in the Meat Production Industry via Scaling Advanced 3D Culture Bioreactors

    SBC: Cambridge Crops, Inc.            Topic: G

    Food production, and in particular animal-derived meat products, are a major source of green-house gases, compounded by the remarkable inefficiency in biomass conversion (grain to dense muscle tissue in meat), along with growing challenges with food safety, quality and nutrition. To address this growing problem, we propose to exploit the emerging field of cellular agriculture (tissue engineering o ...

    STTR Phase I 2020 Department of EnergyARPA-E
  5. Enabling Technology- Reducing Greenhouse Gas Emissions and Energy Demands in the Meat Production Industry via Scaling Advanced 3D Culture Bioreactors

    SBC: Cambridge Crops, Inc.            Topic: G

    Food production, and in particular animal-derived meat products, are a major source of green-house gases, compounded by the remarkable inefficiency in biomass conversion (grain to dense muscle tissue in meat), along with growing challenges with food safety, quality and nutrition. To address this growing problem, we propose to exploit the emerging field of cellular agriculture (tissue engineering o ...

    STTR Phase II 2020 Department of EnergyARPA-E
  6. Flexible Low Temperature CO2 Capture System, E-CACHYS

    SBC: ENVERGEX LLC            Topic: 1

    This project focuses on the design, integration and optimization of a flexible natural gas combined cycle plant with carbon capture, capable of operating in a highly variable renewable energy environment. Renewable energy sources such as wind and solar power offer unique solutions in our quest to reduce global carbon dioxide (CO2) emissions. However, the increasing penetration of these high variab ...

    STTR Phase I 2020 Department of EnergyARPA-E
  7. Flexible Low Temperature CO2 Capture System, E-CACHYS

    SBC: ENVERGEX LLC            Topic: 1

    This project focuses on the design, integration and optimization of a flexible natural gas combined cycle plant with carbon capture, capable of operating in a highly variable renewable energy environment. Renewable energy sources such as wind and solar power offer unique solutions in our quest to reduce global carbon dioxide (CO2) emissions. However, the increasing penetration of these high variab ...

    STTR Phase II 2020 Department of EnergyARPA-E
  8. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Through this STTR contract, we propose to evaluate the efficacy of our vaccine, FlowVax Marburg, in nonhuman primates (NHPs). This will be achieved through four Tasks. In Task 1, we will manufacture the vaccine in a quantity sufficient for the animal studies. In Task 2, we will perform MHC genotyping on a representative population of NHPs and, based on results, select a set of MHC-matched NHPs for ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  9. Marburg Virus Prophylactic Medical Countermeasure

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: CBD18A002

    There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terrible morbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditional vaccines have contributed greatly to public health, they have some limitations especially in the context of operati ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  10. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government